Thank you very much.
I really appreciate the opportunity to talk about things with you today. I would be remiss if I didn't bring up the issue of mefloquine. As you know it's an issue around the world right now, an anti-malaria drug that was used significantly in the past. However, New Zealand has an amazing record in regards to this drug, in being so proactive in ensuring that it wasn't used only as a drug of last resort and that it was monitored. Ground trials were done and if it were approved for use in the operational context, the personnel receiving it were followed up and monitored as well. So you've had very little issue with veterans suffering from the side effects of that drug. I see that you've worked with the United Kingdom defence study on that. It was very exciting for me to see how proactive you were in that. It shows a real concern for your veterans.
You have your veterans advisory board and I understand that members are appointed by the Minister of Veterans Affairs'. I'm just wondering about the process for that. You have seven members and one serving veteran on that board. What kind of an opportunity or input do the veterans themselves—disabled veterans, the ones that you service most—have into who might be considered to sit on that board?